CIK 0001984086 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Septerna, Inc.
Sign in to watch- Ticker
- SEPN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843891440
- Phone
- 650-338-3533
- Business address
- 250 EAST GRAND AVENUE, SUITE 65, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,934,363
- in 1 filing, $3.9M under 10b5-1 plans
Net −$3,934,363. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 61 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-11 | Ezekowitz Alan Director | Sale 10b5-1 | −6,939 | $46.01 | $319K | 110,481 |
| 2026-11-11 | Ezekowitz Alan Director | Sale 10b5-1 | −13,201 | $47.01 | $621K | 97,280 |
| 2026-11-11 | Ezekowitz Alan Director | Sale 10b5-1 | −22,865 | $47.78 | $1.1M | 74,415 |
| 2026-11-11 | Ezekowitz Alan Director | Sale 10b5-1 | −31,572 | $48.70 | $1.5M | 42,843 |
| 2026-11-11 | Ezekowitz Alan Director | Sale 10b5-1 | −4,175 | $49.65 | $207K | 38,668 |
| 2026-11-11 | Ezekowitz Alan Director | Sale 10b5-1 | −2,013 | $50.90 | $102K | 36,655 |
| 2026-11-11 | Ezekowitz Alan Director | Sale 10b5-1 | −1,055 | $51.90 | $55K | 35,600 |
Page 1 of 1 · 7 trades